Fast Company iPad edition promotion


FC Member Blog

Aggressive Prostate Cancer Fro links of london Necklace

BY uklinks oflondon | 03-11-2010 | 3:54 AM
This blog is written by a member of our blogging community and expresses that member's views alone.

Links of London AdMeTech Foundation' Presid and CEO Dr.Links of London Jewellery Faina Shtern said todayNew preliminari data from a pilot studi in the Netherland indic that imag tool mai help address technolog such as MRI and their potenti to elimin unnecessari procedur and to select the most effect and the least invas patient care," said Dr. Shtern.

A bout the AdMeTech Foundation

log onto links of london charms dMeTech Foundat is a nonprofit Links of London Jewellery organ with the mission to end the prostat cancer crisis. AdMeTech provid intern leadership and conduct ground-break program in research and educ to facilit develop of accur diagnost tool for earli detect and minimally-invas treatment of prostat cancer. For more information..
function MR techniqu like Diffus Weight Imaging,"Today' MR imag is get more precis everi dai in defin cancer anatomy. In addition. Dynam Contrast Enhancement,Links of London Jewellery Spectroscopy, and cell specif agent e.g., Combidex have shown to result in improv detect of aggress cancer," said Dr. Barentsz. "These imag links of london bracelet techniqu visual aggress prostat cancer -- togeth with it locat and extent, make it possibl to guid precis biopsi and to administ 'patient-tailor therapy.' The individu treatment is expect to improv outcomes, reduc morbid and save costs. Further research in thi area is of utmost importance," ad Dr. Barentsz, co-lead of AdMeTech' Internat Prostat MRI Work Group,links of london Necklace a research program head by Dr. Shtern and fund through a peer review process by the Telemedicin and Advanc Technolog Research Center of the Depart of Defense. In the most recent meet of the Group, other lead physician and scientist from the Unite State and Europ highlight Diffusion-Weight MRI as on of the most promis emerg imag tool for guidanc of earli diagnosis, biopsi and treatment.

the most challeng clinic dilemma of prostat cancer care as identifi by the hear of the Hous Oversight and Govern Reform Committe and it expert wit last week: to treat or not treat..

done by a world-lead team of research led by Dr.Links of London Jewellery Jell Barentsz,Th preliminari study. Professor of Radiolog and Chair of Research at Radboud University, demonstr a high discriminatori perform of the novel MRI methodolog Diffusion-Weight Image in separ aggress prostat cancer that must be treat from harmless diseas condit that don't requir treatment. The studi of 51 patient will be releas at the European Congress of Radiolog on March 10.
such as blood test PSA and digit rectal exams.Links of London Jewellery The data also show the need for privat and public fund of a larger scale,"Thi emerg data give us great hope for end blind patient care and the relat stagger extent of overdiagnosi and overtreat associ with current screen tools. definit studi on the clinic valu and cost-effect of imag

A bout the Internat Prostat MRI Work Group

multi-disciplinary,Th Internat Prostat MRI Work Group Links of London Jewellery offer a comprehensive. multi-institut approach to the advanc of MRI and Magnet Spectroscopi MRS technolog and their integr with treatment of prostat cancer. A strateg partnership of leader of academia, industry, philanthropi and advocaci groups, the Group seek to develop ground-break research and to develop the near- and long-term research strategi for facilit advanc of MRI/MRS. Thi will includ develop of technic specifications, standard and qualiti control for clinic testing. The Group develop a vision for the futur of image-guided, minimally-invas patient care and clear pathwai for it success realization.
poor specif of current diagnost caus up to 54 percent of men with earli prostat cancer to have unnecessari treatment,Sh emphas that while earli detect is critic to cure prostat cancer and to save lives. which ha dire societ and human costs.

"Improve diagnost tools,Dr. Shtern added. which will correctli identifi patient who requir treatment and those who do not, will save live and improv the qualiti of life in million of men while save billion of dollar in health care costs."

the incid of prostat cancer ha increas sharpli in men in their 50 and younger.Links of London Jewellery Prostat cancer strike as mani as 1 in 6 American men and ha becom even more common than breast cancer strike 1 in 8 women . However,Prost Cancer Facts: Prostat cancer is the most common major cancer in the Unite State and the second most lethal cancer in men. Over the last twenti years. nation invest in research is lag behind and men do not have accurate, life-sav diagnost tool akin to mammograms. The lack of accur diagnost tool ha caus prostat cancer to becom both a patient care crisi and a socio-econom problem. In addit to overdiagnosi and overtreatment, underdiagnosi is widespread. Indeed, under-estim of prostat cancer spread and aggress lead to prostat cancer recurr and progress in as mani as half of all the men undergo treatment. Even though prostat cancer can be cure if detect early, an American man di from prostat cancer everi 19 minutes.